Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

PURPOSE: Metastatic breast cancer (mBC) remains incurable and is associated with low survival rates. This study assessed the efficacy and safety of liposomal irinotecan in heavily pretreated patients with mBC, with or without active brain metastases (BM). METHODS: Following the dose escalation phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdev, Jasgit C., Munster, Pamela, Northfelt, Donald W., Han, Hyo Sook, Ma, Cynthia, Maxwell, Fiona, Wang, Tiffany, Belanger, Bruce, Zhang, Bin, Moore, Yan, Thiagalingam, Arunthathi, Anders, Carey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921078/
https://www.ncbi.nlm.nih.gov/pubmed/33201358
http://dx.doi.org/10.1007/s10549-020-05995-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921078/
https://www.ncbi.nlm.nih.gov/pubmed/33201358
http://dx.doi.org/10.1007/s10549-020-05995-7

Ejemplares similares